The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized head-to-head prospective study of pharmacokinetic and pharmacodynamic properties of leuprolide acetate formulations: 7.5 mg single depot subcutaneous vs 7.5 mg intramuscular microsphere.
 
Daniel R. Saltzstein
Consulting or Advisory Role - Bayer; Janssen; Medivation; Tolmar
Speakers' Bureau - Bayer; Janssen; Medivation
 
Judd W. Moul
Honoraria - Dendreon; Ferring; Janssen; Tolmar
Consulting or Advisory Role - Genomic Health; Myriad Pharmaceuticals; Theralogix
Speakers' Bureau - Dendreon; Ferring; Genomic Health; Janssen; Myriad Pharmaceuticals; Sanofi
Travel, Accommodations, Expenses - Dendreon; Ferring; Genomic Health; Janssen; Myriad Pharmaceuticals; Sanofi; Theralogix; Tolmar
 
Stephan de la Motte
Employment - SynteractHCR
Research Funding - SynteractHCR (Inst)
 
John A. McLane
Employment - Tolmar
Leadership - Clinquest
Stock and Other Ownership Interests - Roche Pharma AG
Patents, Royalties, Other Intellectual Property - Clinquest; Clinquest (Inst)
 
David W. Osborne
Employment - Tolmar
Leadership - Tolmar
Patents, Royalties, Other Intellectual Property - Tolmar
 
Alex Yang
Leadership - Xelay Acumen
Consulting or Advisory Role - Tolmar
 
Raoul S. Concepcion
Consulting or Advisory Role - Astellas Pharma; Bayer; Chan Soon-Shiong Institute for Advanced Health; Genomic Health
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen
Research Funding - Astellas Pharma (Inst); Dendreon (Inst); Janssen (Inst); Takeda (Inst)